SCHEMBL10298239

SCHEMBL10298239

COC(=O)c1c(C(=O)c2ccccc2)sc(N2CCOCC2)c1C(=O)CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ HSD17B10 Q99714 2/20 0.46
▸ MRGPRX4 Q96LA9 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PRKDC P78527 1/20 0.41
▸ CHRNA7 P36544 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288334 0.91 ALDH1A1 (0.50) ALDH1A1ALOX5HSD17B10MRGPRX4KDM4E
SCHEMBL10298243 0.84 HSD17B10 (0.51) ALDH1A1HSD17B10KDM4EMAPK1MEN1
SCHEMBL10298244 0.81 ALDH1A1 (0.44) ALDH1A1HSD17B10MRGPRX4KDM4EMAPK1
SCHEMBL10308315 0.75 HSD17B10 (0.46) ALDH1A1HSD17B10KDM4EMAPK1GAA
SCHEMBL10288080 0.75 HSD17B10 (0.53) ALDH1A1HSD17B10KDM4EMAPK1GAA
SCHEMBL10308310 0.72 HSD17B10 (0.38) ALDH1A1HSD17B10MRGPRX4KDM4EGAA
SCHEMBL10288078 0.72 ALDH1A1 (0.51) ALDH1A1HSD17B10MRGPRX4KDM4EMAPK1
SCHEMBL17237505 0.70 PIK3CA (0.51) ALDH1A1ALOX5HSD17B10KDM4EMAPK1
SCHEMBL4487982 0.69 ALDH1A1 (0.56) ALDH1A1ALOX5KDM4EMAPK1HTT
SCHEMBL3121821 0.68 PIK3CA (0.44) ALDH1A1HSD17B10MRGPRX4KDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 — — US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 — — US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 — — US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 — — US disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 — — US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885ALOX5 524/4885HSD17B10 475/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 429/4885ALOX5 524/4885HSD17B10 475/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 395/4885ALOX5 302/4885HSD17B10 405/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 ALDH1A1 395/4885ALOX5 302/4885HSD17B10 405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback